In today’s recent session, 0.66 million shares of the CorMedix Inc (NASDAQ:CRMD) have been traded, and its beta is 1.58. Most recently the company’s share price was $6.14, and it changed around $0.49 or 8.58% from the last close, which brings the market valuation of the company to $342.70M. CRMD at last check was trading at a discount to its 52-week high of $7.00, offering almost -14.01% off that amount. The share price’s 52-week low was $2.57, which indicates that the recent value has risen by an impressive 58.14% since then. We note from CorMedix Inc’s average daily trading volume that its 10-day average is 0.91 million shares, with the 3-month average coming to 550.19K.
CorMedix Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended CRMD as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. CorMedix Inc is expected to report earnings per share of -0.1 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
CorMedix Inc (NASDAQ:CRMD) trade information
Instantly CRMD has been showing a green trend so far today with a performance of 8.58% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 6.15 on recent trading dayincreased the stock’s daily price by 0.16%. The company’s shares are currently up 63.16% year-to-date, but still up 18.90% over the last five days. On the other hand, CorMedix Inc (NASDAQ:CRMD) is 35.13% up in the 30-day period. We can see from the shorts that 10.2 million shares have been sold at a short interest cover period of 21.26 day(s).
The consensus price target as assigned by Wall Street analysts is $9, which translates to bulls needing to increase their stock price by 31.78% from its current value. Analyst projections state that CRMD is forecast to be at a low of $9 and a high of $9.
CorMedix Inc (CRMD) estimates and forecasts
CorMedix Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 85.35 percent over the past six months and at a 36.26% annual growth rate that is well above the industry average of 18.30%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 41.20% in revenue this quarter, and will report an increase of 96.20% in the next quarter.
Consensus estimates provided by 4 financial analysts predict the company will bring in an average of 10.84M in revenue for the current quarter. 4 analysts expect CorMedix Inc to make 18.23M in revenue for the current ending quarter.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 9.58%.
CRMD Dividends
CorMedix Inc’s next quarterly earnings report is expected to be released in September.
CorMedix Inc (NASDAQ:CRMD)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.95% of CorMedix Inc shares, and 30.81% of them are in the hands of institutional investors. The stock currently has a share float of 31.10%. CorMedix Inc stock is held by 123.0 institutions, with BLACKROCK INC. being the largest institutional investor. By 2024-06-30, it held 6.1796% of the shares, which is about 3.55 million shares worth $15.39 million.
VANGUARD GROUP INC, with 5.0476% or 2.9 million shares worth $12.57 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
